LVADs: Thoratec study a Roadmap to lower-risk patients?
Results from Thoratec's Roadmap study of its HeartMate II implantable heart pump in less-sick heart failure patients shows significant benefit over optimal medical therapy alone.
HeartWare International Inc., International Society for Heart & Lung Transplantation, Thoratec Corp.News Well, Clinical Trials, Cardiac Assist Devicesread more
Source: Mass Device - Category: Medical Equipment Authors: Brad Perriello Source Type: news
More News: Cardiology | Clinical Trials | Heart | Heart Failure | Heart Transplant | Lung Transplant | Medical Devices | Study | Transplants